Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerability and effectiveness of low-dose oral minoxidil for alopecia in patients with breast cancer: A retrospective cohort study.
Zaminski D, Sikora M, Nohria A, Desai D, Buontempo M, Caplan AS, Lacouture M, Garshick M, Olsen EA, Shapiro J, Mazori DR, Lo Sicco KI. Zaminski D, et al. Among authors: lacouture m. J Am Acad Dermatol. 2024 Dec 3:S0190-9622(24)03289-4. doi: 10.1016/j.jaad.2024.11.048. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39637983 No abstract available.
Response to Kang et al, "Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study".
Kearney CA, Brinks AL, Needle CD, Shapiro J, Lacouture ME, Lo Sicco KI. Kearney CA, et al. Among authors: lacouture me. J Am Acad Dermatol. 2024 Dec 24:S0190-9622(24)03402-9. doi: 10.1016/j.jaad.2024.11.073. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39725217 No abstract available.
Phenotype/Immunologic Profiling in ircAEs-Response.
Goleva E, Lacouture ME, Moy AP, Kern JA, Leung DYM. Goleva E, et al. Among authors: lacouture me. Clin Cancer Res. 2024 Dec 16;30(24):5694. doi: 10.1158/1078-0432.CCR-24-2949. Clin Cancer Res. 2024. PMID: 39676538 No abstract available.
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.
Apalla Z, Freites-Martinez A, Grafanaki K, Ortiz-Brugues A, Nikolaou V, Fattore D, Sollena P, Deverapalli S, Babakoohi S, Galimont A, Kluger N, Beylot-Barry M, Larocca C, Iriarte C, Smith J, Tattersall I, Dodiuk-Gad R, Sauder M, Carrera C, Kwong B, Whitley M, Leboeuf N, Romano P, Starace M, Mateeva V, Riganti J, Hirner J, Patel AB, Reyes-Habito CM, Kraehenbuehl L, Kheterpal M, Fida M, Hassel J, Lacouture M, Sibaud V. Apalla Z, et al. Among authors: lacouture m. J Eur Acad Dermatol Venereol. 2024 Oct 26. doi: 10.1111/jdv.20391. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39460590
Clinical presentations of skin of color in oncodermatology.
Chen A, Lavin L, Markova A, Lacouture ME. Chen A, et al. Among authors: lacouture me. J Am Acad Dermatol. 2024 Sep 16:S0190-9622(24)02817-2. doi: 10.1016/j.jaad.2024.08.060. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39293574 No abstract available.
Omalizumab for Treatment of Anti-GD2 Antibody-related Urticaria.
Glincher R, Lentini-Rivera A, Andre Jones L, D'Andrea L, Durney C, Kasper C, Lin Y, Shrager L, Markova A, Lacouture M, Modak S. Glincher R, et al. Among authors: lacouture m. J Pediatr Hematol Oncol. 2024 Oct 1;46(7):e531-e533. doi: 10.1097/MPH.0000000000002939. Epub 2024 Aug 22. J Pediatr Hematol Oncol. 2024. PMID: 39177945
336 results